CORMEDIX INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $62.8M | $53.3M |
| FY2022 | — | $55.1M | $43.1M |
| FY2023 | — | $70.1M | $43.6M |
| FY2024 | — | $84.7M | $40.7M |
| FY2025 | — | $405.3M | $144.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $62.8M | $53.3M |
| FY2022 | — | $55.1M | $43.1M |
| FY2023 | — | $70.1M | $43.6M |
| FY2024 | — | $84.7M | $40.7M |
| FY2025 | — | $405.3M | $144.8M |